Characteristics and advantages of adeno-associated virus vector-mediated gene therapy for neurodegenerative diseasesYuan Qu, Yi Liu, Ahmed Fayyaz Noor, Johnathan Tran, Rui Li931-938
Gene expression changes in dorsal root ganglia following peripheral nerve injury: roles in inflammation, cell death and nociceptionSarah L.Martin, Adam J.Reid, Alexei Verkhratsky, Valerio Magnaghi, Alessandro Faroni939-947
Nicotinamide adenine dinucleotide phosphate oxidase activation and neuronal death after ischemic strokeJiamei Shen, Radhika Rastogi, Xiaokun Geng, Yuchuan Ding948-953
Autophagy: novel insights into therapeutic target of electroacupuncture against cerebral ischemia/reperfusion injuryYa-Guang Huang, Wei Tao, Song-Bai Yang, Jin-Feng Wang, Zhi-Gang Mei, Zhi-Tao Feng954-961
Lessons from glaucoma: rethinking the fluid-brain barriers in common neurodegenerative disordersFrancisco Javier Carreras962-966
Busting the myth: more good than harm in transgenic cellsGonzalo Pi?ero, Patricia Setton-Avruj967-968
Muscle secretion of toxic factors, regulated by miR126-5p, facilitates motor neuron degeneration in amyotrophic lateral sclerosisRoy Maimon, Eran Perlson969-970
Preliminary in vitro evaluation of neuroprotective and monoamine oxidase type B inhibitory effects of newly synthesized 8-aminocaffeinesMagdalena Kondeva-Burdina, Maya Georgieva, Alexandra Kasabova-Angelova, Virginia Tzankova, Alexander Zlatkov971-972
Therapeutic exploitation of the S-nitrosoglutathione/S-nitrosylation mechanism for the treatment of contusion spinal cord injuryMushfiquddin Khan, Inderjit Singh973-974
